{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:12:33Z","timestamp":1788307953526,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00726-012-1223-0","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T23:00:32Z","timestamp":1327532432000},"page":"1499-1507","source":"Crossref","is-referenced-by-count":21,"title":["Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Angelo","family":"Zinellu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sotgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Loriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Ercole","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"1223_CR1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5414\/CNP61377","volume":"61","author":"R Agarwal","year":"2004","unstructured":"Agarwal R (2004) Chronic kidney disease is associated with oxidative stress independent of hypertension. Clin Nephrol 61:377\u2013383","journal-title":"Clin Nephrol"},{"key":"1223_CR2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267\u20131278","journal-title":"Lancet"},{"key":"1223_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","volume":"111","author":"V Cachofeiro","year":"2008","unstructured":"Cachofeiro V, Goicochea M, de Vinuesa SG, Oubi\u00f1a P, Lahera V, Lu\u00f1o J et al (2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 111:S4\u2013S9","journal-title":"Kidney Int Suppl"},{"key":"1223_CR4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/elps.200305768","volume":"25","author":"C Carru","year":"2004","unstructured":"Carru C, Deiana L, Sotgia S, Pes GM, Zinellu A et al (2004) Plasma thiols redox status by laser-induced fluorescence capillary electrophoresis. Electrophoresis 25:882\u2013889","journal-title":"Electrophoresis"},{"key":"1223_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-0-387-33504-9_25","volume":"583","author":"MJ Choi","year":"2006","unstructured":"Choi MJ, Kim JH, Chang KJ (2006) The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet. Adv Exp Med Biol 583:235\u2013242","journal-title":"Adv Exp Med Biol"},{"key":"1223_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1326.2009.01152.x","volume":"12","author":"S Conard","year":"2010","unstructured":"Conard S, Bays H, Leiter LA, Bird S, Lin J, Hanson ME, Shah A, Tershakovec AM et al (2010) Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither. Diabetes Obes Metab 12:210\u2013218","journal-title":"Diabetes Obes Metab"},{"key":"1223_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MED.0b013e3283295297","volume":"16","author":"E Dembowski","year":"2009","unstructured":"Dembowski E, Davidson MH (2009) Statin and ezetimibe combination therapy in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 16:183\u2013188","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1223_CR8","doi-asserted-by":"crossref","first-page":"c3","DOI":"10.1159\/000079921","volume":"98","author":"SH Diepeveen","year":"2004","unstructured":"Diepeveen SH, Verhoeven GH, van der Palen J, Dikkeschei BL, van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF et al (2004) Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy. Nephron Clin Pract 98:c3\u2013c7","journal-title":"Nephron Clin Pract"},{"key":"1223_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1517\/14740338.3.2.101","volume":"3","author":"J Dierkes","year":"2004","unstructured":"Dierkes J, Westphal S, Luley C et al (2004) The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opin Drug Saf 3:101\u2013111","journal-title":"Expert Opin Drug Saf"},{"key":"1223_CR10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","volume":"48","author":"E Dounousi","year":"2006","unstructured":"Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC, Tsakiris D et al (2006) Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752\u2013760","journal-title":"Am J Kidney Dis"},{"key":"1223_CR11","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O\u2019Neill KA, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA et al (2005) The target of ezetimibe is Niemann\u2013Pick c1-like 1 (npc1l1). Proc Natl Acad Sci USA 102:8132\u20138137","journal-title":"Proc Natl Acad Sci USA"},{"key":"1223_CR12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131370","journal-title":"N Engl J Med"},{"key":"1223_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-0-387-33504-9_13","volume":"583","author":"SH Hansen","year":"2006","unstructured":"Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F et al (2006) The important role of taurine in oxidative metabolism. Adv Exp Med Biol 583:129\u2013135","journal-title":"Adv Exp Med Biol"},{"key":"1223_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.1992.72.1.101","volume":"72","author":"RJ Huxtable","year":"1992","unstructured":"Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101\u2013163","journal-title":"Physiol Rev"},{"key":"1223_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5414\/CNP58190","volume":"58","author":"TA Ikizler","year":"2002","unstructured":"Ikizler TA, Morrow JD, Roberts LJ, Evanson JA, Becker B, Hakim RM, Shyr Y, Himmelfarb J et al (2002) Plasma F-isoprostane levels are elevated in chronic hemodialysis patients. Clinl Nephrol 58:190\u2013197","journal-title":"Clinl Nephrol"},{"key":"1223_CR16","author":"CJ Jong","year":"2011","unstructured":"Jong CJ, Azuma J, Schaffer S (2011) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids. doi: 10.1007\/s00726-011-0962-7","journal-title":"Amino Acids"},{"key":"1223_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1758-5996-2-34","volume":"7","author":"AL Kater","year":"2010","unstructured":"Kater AL, Batista MC, Ferreira SR (2010) Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects. Diabetol Metab Syndr 7:34\u201337","journal-title":"Diabetol Metab Syndr"},{"key":"1223_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","volume":"13","author":"MS Kostapanos","year":"2008","unstructured":"Kostapanos MS, Milionis HJ, Elisaf MS (2008) An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther 13:157\u2013174","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1223_CR19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11745-011-3539-z","volume":"46","author":"MS Kostapanos","year":"2011","unstructured":"Kostapanos MS, Spyrou AT, Tellis CC, Gazi IF, Tselepis AD, Elisaf M, Liberopoulos EN et al (2011) Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids 46:341\u2013348","journal-title":"Lipids"},{"key":"1223_CR20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1523-1755.2003.00838.x","volume":"63","author":"G Manjunath","year":"2003","unstructured":"Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63:1121\u20131129","journal-title":"Kidney Int"},{"key":"1223_CR21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0091270003255920","volume":"43","author":"HJ Milionis","year":"2003","unstructured":"Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS et al (2003) Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol 43:825\u2013830","journal-title":"J Clin Pharmacol"},{"key":"1223_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-009-0247-6","volume":"38","author":"S Murakami","year":"2010","unstructured":"Murakami S, Sakurai T, Tomoike H, Sakono M, Nasu T, Fukuda N et al (2010) Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. Amino Acids 38:271\u2013278","journal-title":"Amino Acids"},{"key":"1223_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hci093","volume":"98","author":"HT Ong","year":"2005","unstructured":"Ong HT (2005) The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. QJM 98:599\u2013614","journal-title":"QJM"},{"key":"1223_CR24","first-page":"464","volume":"29","author":"MJ Puchades Montesa","year":"2009","unstructured":"Puchades Montesa MJ, Gonz\u00e1lez Rico MA, Sol\u00eds Salguero MA, Torregrosa Maicas I, Tormos Mu\u00f1oz MC, Saez Tormo G, Juan Garcia I, Miguel Carrasco A et al (2009) Study of oxidative stress in advanced kidney disease. Nefrologia 29:464\u2013473","journal-title":"Nefrologia"},{"key":"1223_CR25","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154\u20132169","journal-title":"Circulation"},{"key":"1223_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1139\/Y08-110","volume":"87","author":"SW Schaffer","year":"2009","unstructured":"Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91\u201399","journal-title":"Can J Physiol Pharmacol"},{"key":"1223_CR27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"PS Sever","year":"2003","unstructured":"Sever PS, Dahl\u00f6f B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O\u2019Brien E, Ostergren J et al (2003) ASCOT investigators, prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:1149\u20131158","journal-title":"Lancet"},{"key":"1223_CR28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2007.09.099","volume":"101","author":"EA Stein","year":"2008","unstructured":"Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR (2008) Efficacy and tolerability of fluvastatin XL 80\u00a0mg alone, ezetimibe alone, and the combination of fluvastatin XL 80\u00a0mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Am J Cardiol 101:490\u2013496","journal-title":"Am J Cardiol"},{"key":"1223_CR29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ndt\/17.6.1050","volume":"17","author":"ME Suliman","year":"2002","unstructured":"Suliman ME, B\u00e1r\u00e1ny P, Divino Filho JC, Qureshi AR, Stenvinkel P, Heimb\u00fcrger O, Anderstam B, Lindholm B, Bergstr\u00f6m J et al (2002) Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. Nephrol Dial Transpl 17:1050\u20131056","journal-title":"Nephrol Dial Transpl"},{"key":"1223_CR30","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1053\/ajkd.2003.50093","volume":"41","author":"ME Suliman","year":"2003","unstructured":"Suliman ME, Stenvinkel P, B\u00e1r\u00e1ny P, Heimb\u00fcrger O, Anderstam B, Lindholm B (2003) Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41:S89\u2013S95","journal-title":"Am J Kidney Dis"},{"key":"1223_CR31","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","volume":"290","author":"ND Vaziri","year":"2006","unstructured":"Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290:F262\u2013F272","journal-title":"Am J Physiol Renal Physiol"},{"key":"1223_CR32","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","volume":"161","author":"V Witko-Sarsat","year":"1998","unstructured":"Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeill\u00e8re-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Dr\u00fceke T, Descamps-Latscha B et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524\u20132532","journal-title":"J Immunol"},{"key":"1223_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","volume":"47","author":"MI Yilmaz","year":"2006","unstructured":"Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C (2006) The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47:42\u201350","journal-title":"Am J Kidney Dis"},{"key":"1223_CR34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00726-002-0211-1","volume":"23","author":"H Yokogoshi","year":"2002","unstructured":"Yokogoshi H, Oda H (2002) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. Amino Acids 23:433\u2013439","journal-title":"Amino Acids"},{"key":"1223_CR35","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/elps.200305570","volume":"24","author":"A Zinellu","year":"2003","unstructured":"Zinellu A, Carru C, Galistu F, Usai MF, Pes GM, Baggio G, Federici G, Deiana L (2003) N-methyl-d-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement. Electrophoresis 24:2796\u20132804","journal-title":"Electrophoresis"},{"key":"1223_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00726-007-0022-5","volume":"36","author":"A Zinellu","year":"2009","unstructured":"Zinellu A, Sotgia S, Scanu B, Chessa R, Gaspa L, Franconi F, Deiana L, Carru C (2009) Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications. Amino Acids 36:35\u201341","journal-title":"Amino Acids"},{"key":"1223_CR37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000319012","volume":"32","author":"A Zinellu","year":"2010","unstructured":"Zinellu A, Loriga G, Scanu B, Pisanu E, Sanna M, Deiana L, Satta AE, Carru C (2010) Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease. Am J Nephrol 32:242\u2013248","journal-title":"Am J Nephrol"},{"key":"1223_CR38","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/elps.201100056","volume":"32","author":"A Zinellu","year":"2011","unstructured":"Zinellu A, Sotgia S, Deiana L, Carru C (2011a) Field-amplified online sample stacking capillary electrophoresis UV detection for plasma malondialdehyde measurement. Electrophoresis 32:1893\u20131897","journal-title":"Electrophoresis"},{"key":"1223_CR39","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s00216-010-4648-x","volume":"399","author":"A Zinellu","year":"2011","unstructured":"Zinellu A, Sotgia S, Deiana L, Carru C (2011b) Field-amplified sample injection combined with pressure-assisted capillary electrophoresis UV detection for the simultaneous analysis of allantoin, uric acid, and malondialdehyde in human plasma. Anal Bioanal Chem 399:2855\u20132861","journal-title":"Anal Bioanal Chem"},{"key":"1223_CR40","doi-asserted-by":"crossref","first-page":"F1203","DOI":"10.1152\/ajprenal.00045.2010","volume":"299","author":"C Zoja","year":"2010","unstructured":"Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G (2010) Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am J Physiol Renal Physiol 299:F1203\u2013F1211","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-012-1223-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-012-1223-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T01:24:52Z","timestamp":1686705892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-012-1223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1007\/s00726-012-1223-0","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}